Menu
Not yet recruiting NCT06929221

The Effect of Bedside Whiteboard Use on Anxiety, Depression and Nursing Care in Chronic Obstructive Pulmonary Patients

No phase Interventional COPD Nursing Care

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: use of whiteboard.
Who it may be relevant to
Registry conditions: COPD, Nursing Care. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

ABSTRACT Chronic obstructive pulmonary disease (COPD) is a disease characterized by the inability of the body to adequately exchange gases, resulting in progressive shortness of breath that can form secretions and compromise the performance of daily activities. COPD is reported as the third most common cause of death worldwide, with 3.23 million deaths in 2019. Anxiety and depression are common in individuals with COPD. However, COPD is more common in patients with other chronic diseases such as hypertension, diabetes, cancer or musculoskeletal disorders. Communication is a key component in interprofessional care as well as in improving patient care outcomes. Strategies to address gaps in the quality of information and communication between patients, caregivers and professionals improve patient safety as well as quality of care. One of these strategies is the use of whiteboards at the bedside. The use of whiteboards at the bedside has emerged as a strategy to improve interprofessional team participation, communication and information sharing with care teams, patients and families. This study will be conducted in randomized controlled single blind parallel groups to examine the effect of bedside whiteboard use on anxiety, depression and nursing care satisfaction in COPD patients. The research will consist of patients who are hospitalized in Atatürk University Research Hospital Chest Diseases Clinic and who meet the inclusion criteria. In the results of the research, it is thought that the use of whiteboard will affect the communication between health care team members.

Interventions

  • Other use of whiteboard
    Patients will be followed up for 7 days. Routine nursing care will be applied to the control group. The following information will be included on the whiteboard fixed in the patient room for the intervention group. * Nurse's name * Doctor's name * Treatment times during the day * Nursing interventions and hours for the diagnoses considered for the patient's major problems * Timing of diagnostic and imaging techniques to be performed on the patient * Content of appropriate discharge education fo

Primary outcome measures

  • How does the use of whiteboard affect anxiety, depression and nursing care satisfaction in COPD patients? [Time frame: From registration until the end of the 3th month]
  • How does the use of whiteboard affect anxiety, depression and nursing care satisfaction in COPD patients? [Time frame: From registration until the end of the 3th month]

Eligibility criteria

Inclusion criteria

  • 18 years of age or older
  • Having a medical diagnosis of COPD
  • To be in a condition to be followed up with at least 7 days

Exclusion criteria

  • \- Having strong reading and comprehension skills

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06929221 · RDENİZ02

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗